Philips initiated a voluntary recall for some of its sleep apnea machines and ventilators. The American multinational conglomerate company cited concerns for a foam component that may get detached or degrade and become toxic when inhaled by the user.
It was said that if such a thing happens, there is a possibility it could cause health issues including the development of cancer due to toxic and carcinogenic effects. To prevent this and protect the users, Philips issued a recall notification on Monday, June 14.
The affected devices and Philips’ announcement
As per Fox Business, the Philips recall will affect three to four million units of certain machine models that feature Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAC) and the mechanical ventilator machines. It was revealed that the company already issued the first warning over the issue in April.
Philips announced its voluntary recall notification after consulting with regulatory agencies. The company said that with the recalled products, the company will immediately take corrective actions that include the distribution of updated instructions for the repair and replacement of the affected items. As of this time, Philips is continuously monitoring reports of safety issues and so far, it has not received any reports of death due to the product issues.
It was added that due to potential risks of exposure, users may experience headaches, respiratory issues, irritation, inflammation and possible toxic or carcinogenic effects. But fortunately, there is no report of these effects yet related to chemical emissions.
“We deeply regret any concern and inconvenience that patients using the affected devices will experience because of the proactive measures we are announcing today to ensure patient safety,” Philips CEO, Frans van Houten, said in a press release. “In consultation with the relevant regulatory agencies and in close collaboration with our customers and partners, we are working hard towards a resolution. Patient safety is at the heart of everything we do at Philips.”
How Philips will solve the issue
Reuters reported that Philips is now working with the health authorities and regulators for the safety of the consumers. It is looking for a way for the safe replacement of the foam that may potentially become toxic and cause cancer.
It was added that Philips is not conducting tests and it needs to get good results so it can pass the regulatory requirements. The company will also be replacing the products that cannot be repaired or updated.


US Stock Futures Steady as Oil Prices Ease, Iran Talks Boost Market Sentiment
Oil Prices Rise as U.S.-Iran Conflict Fuels Strait of Hormuz Supply Fears
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Asian Currencies Slip as Stronger US Dollar, Iran Tensions Pressure Regional FX
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
China Inflation Cools in June as Producer Prices Hit Four-Year High
Gold Price Climbs Over 1% as Dollar Weakens, Fed Rate Debate and Iran Tensions Remain in Focus
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal
Japan Wholesale Inflation Jumps as Energy Shock Drives Import Costs Higher
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Japan Eyes Bigger GPIF Investment in Domestic Assets as BOJ Independence Concerns Grow
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Japanese Yen Rises as Pension Fund Plan and BOJ Rate Hike Bets Weigh on Dollar
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 



